Not Tagged
beigene
[]
#ascogi23 evaluation of tumor inmune micro environment of #her2+ tumors demonstrated a low immunogenic signature in gastro esophageal cancers using data from #ngs caris. thus her2+ tumors may not respond to #immunotherapy 
Gastrointestinal Oncologist, Physician Scientist & Mother CMO PanOncology Trials. Tweets are mine.